Atlas Trials

Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer

Clinical trial NCT02141438 · COMPLETED

Trial details

NCT number
NCT02141438
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Castration-resistant Prostate Cancer
Start date
2014-08-20
Primary completion
2024-08-02
Enrollment
1472

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.